Immunoglobulins Market Is Likely to Experience a Strong Growth During 2021-2026

Immunoglobulins Market Is Likely to Experience a Strong Growth During 2021-2026
2 min read
22 September 2022

The report entitled; “Immunoglobulins Market, Trends, Dynamics, and Market Analysis,” recently published by Stratview Research offers a comprehensive outlook of the industry. This report by Product (IgG, IgA, IgM, IgE, IgD), By Mode of Delivery (Intravenous, Subcutaneous), By Application (Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Others) and Region - COVID-19 Impact Analysis and Forecast to 2026.

To get detailed insights about this study, click here: https://www.stratviewresearch.com/Request-Sample/2326/Immunoglobulins-Market.html#form

Key Players:

  • Baxter international Inc. (US)
  • CSL Ltd. (Australia)
  • Grifols S.A (Spain)
  • Octapharma AG (Switzerland)
  • Kedrion Biopharma Inc. (US)
  • LFB group (France)
  • Biotest AG (Germany)
  • China Biologics Products, Inc. (China)
  • Shire (Baxalta) (US)
  • Bayer Healthcare (Germany).

Segment Analysis

Based on application, the market has been classified into hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), immunodeficiency disease, myasthenia gravis, and others. The hypogammaglobulinemia segment accounted for the largest market share in 2020. This is ascribed to the substantial rise in the prevalence of hypogammaglobulinemia disorder around the world over the years. For instance, hypogammaglobulinemia is the most common chronic immune defect in patients with lymphoproliferative disorders (LPDs). Its prevalence rate is ~2 per 100,000 population yearly, worldwide, which further boosts the segment growth.

The market in North America accounted for the largest share in 2020 and is projected to continue its dominance during the review period. This is mainly attributed to increasing healthcare expenditure, the growing inclination of clinicians towards immunodeficiency therapies, and the rising level of consciousness for the products involved in the treatment of immunodeficiency disorders. Moreover, beneficial government initiatives and a rise in the number of research partnerships further proliferate regional growth.

Competitive Benchmarking

Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Share your requirements at -

Stratview Research

E-mail: [email protected]

Direct: +1-313-307-4176

About Stratview Research:

Stratview Research is a credible source for gaining market intelligence to exponentially accelerate the user’s business. Our team of veterans and analysts have extensive experience in executing custom research projects for mid-sized to fortune companies, in the areas of Market Assessment, Opportunity Screening, Competitive Intelligence, Due Diligence, Target Screening, Market Entry Strategy, and more.

In case you have found a mistake in the text, please send a message to the author by selecting the mistake and pressing Ctrl-Enter.
Ethan 0
Joined: 1 year ago
Comments (0)

    No comments yet

You must be logged in to comment.

Sign In / Sign Up